tcmc is a biotechnology CDMO advancing cell and gene therapies from discovery to commercialization. The company delivers end-to-end solutions, including IND-enabling CMC development, clinical manufacturing, and commercial-scale production.

tcmc specializes in premium lentiviral vectors (LVVs) and advanced cell therapies, including CAR-T products, supporting programs from early R&D through full-scale commercialization. The company also produces non-genetically modified cell therapies, including DC, CIK, NK, and stem cells. Every project is backed by comprehensive regulatory and CMC support, ensuring compliance and confidence at every stage.

From pioneering research to life-changing therapies, tcmc partners with companies to accelerate the next generation of medicine.

tcmc

Org chart

Teams

Offices

tcmc

Org chart

Teams

Offices

Related companies